Gruenstadt, Germany

Achim Möller

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Abbott Gmbh & Co Kg, Basf Aktiengesellschaft. Active years: 2000-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Achim Möller. Retrieved from https://idiyas.com/inventor/achim-möller-vvt9l7vc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3


Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 30(Granted Patents)


Location History:

  • Grunstadt, DE (2000)
  • Grünstadt, DE (2007 - 2011)

Company Filing History:


Years Active: 2000-2011

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Achim Moller: Innovating Calpain Inhibition from Grunstadt

Introduction

Achim Moller is a prominent inventor based in Grunstadt, Germany. With a focus on innovative solutions in the field of biochemistry, he has made significant contributions to medical science. His work primarily involves the development of compounds that have therapeutic potential.

Latest Patents

Achim Moller holds a patent for "Ketobenzamides as calpain inhibitors." This innovation presents a promising avenue for treating various diseases where calpain activity is implicated. The patent exemplifies his expertise in biochemical research and development.

Career Highlights

Achim's career is marked by his association with BASF Aktiengesellschaft, a leading global chemical company. His role encompasses research and development aimed at creating effective solutions for pharmaceutical applications. His dedication to innovation surrounds improving human health through advanced chemistry.

Collaborations

Throughout his professional journey, Achim has collaborated with esteemed colleagues, including Wilfried Lubisch and Hans-Jorg Treiber. These partnerships have fostered a creative environment, enhancing the development of his patent and contributing to the broader goals of their research team.

Conclusion

Achim Moller’s contributions to science and innovation are commendable. His patent for calpain inhibitors reflects his valuable insights and expertise in the biochemistry field. As he continues to work at BASF Aktiengesellschaft, the future holds promise for further breakthroughs in medical science, driven by his inventive spirit.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…